TCTR20180612002Completed未知
Simplified warfarin dosing formula to guide initiation dose in Thai patients.
Faculty of Medicine, Chiang Mai University0 sites640 target enrollmentStarted: June 12, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 640
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to 0 N/A (No limit) (—)
- Sex
- All
Inclusion Criteria
- •The patient who took warfarin had stable INR target 2.0-3.0 in two follow up visit after received warfarin
Exclusion Criteria
- •1. The patient who took warfarin had stable INR target 2.0-3.0 less than two follow up visit after received warfarin
- •2. Post valve replacement operation less than 1 year
Investigators
Similar Trials
Active, not recruiting
Phase 3
The efficacy of different warfarin starting doses (3 mg versus 5 mg) and the corresponding dosing schedule in patients diagnosed with deep vein thrombosisThe efficacy of different warfarin initiating dose in patients diagnosed with venous thromboembolismwarfarin,initiating dose,efficacy,venous thromboembolismTCTR20180328002Faculty of Medicine Siriraj Hospital, Mahidol University56
Completed
Phase 3
A clinical trial studying if the 10mg initiation dose achieves anticoagulation faster than the 5mg initiation dose in the treatment of acute deep vein thrombosis, while maintaining safety and efficacy.CTRI/2016/10/007346Fluid Research Grant Christian Medical College Vellore60
Completed
Not Applicable
Evaluation of patients’ warfarin knowledge and outcomes following secondary warfarin education (in an outpatient setting) compared with standard inpatient education, as measured by the Oral Anticoagulation Knowledge test.Anticoagulation control - Warfarin educationPublic Health - Health promotion/educationCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12615000429550Royal Melbourne Hospital40
Completed
Not Applicable
Appropriate Dose of Initial Heparin Administration without Glycoprotein Inhibitor on Catheter InterventioCoronary/peripheral artery disease planned with catheter interventionJPRN-UMIN000014180ishiarai Heart Center Hospital160
Completed
Not Applicable
Continuous Warfarin (Antithrombin therapy) administration versus Heparin bridge therapy in post colon polypectomy hemorrhagecolon polypJPRN-UMIN000023720Osaka City University Graduate School of Medicine316